Related Experiment Video
Updated: Jun 20, 2026

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Published on: June 5, 2021
Development of Fluorescence-Based Assays for Key Viral Proteins in the SARS-CoV-2 Infection Process and Lifecycle
Mingzhenlong Deng1, Chuang Zhang1, Wanli Yan1
1State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Provincial Key Laboratory of Pharmaceutics, School of Pharmacy, Guizhou Medical University, Guiyang 550004, China.
Abstract:
Since the appearance of SARS-CoV-2 in 2019, the ensuing COVID-19 (Corona Virus Disease 2019) pandemic has posed a significant threat to the global public health system, human health, life, and economic well-being. Researchers worldwide have devoted considerable efforts to curb its spread and development. The latest studies have identified five viral proteins, spike protein (Spike), viral main protease (3CLpro), papain-like protease (PLpro), RNA-dependent RNA polymerase (RdRp), and viral helicase (Helicase), which play crucial roles in the invasion of SARS-CoV-2 into the human body and its lifecycle. The development of novel anti-SARS-CoV-2 drugs targeting these five viral proteins holds immense promise. Therefore, the development of efficient, high-throughput screening methodologies specifically designed for these viral proteins is of utmost importance. Currently, a plethora of screening techniques exists, with fluorescence-based assays emerging as predominant contenders. In this review, we elucidate the foundational principles and methodologies underpinning fluorescence-based screening approaches directed at these pivotal viral targets, hoping to guide researchers in the judicious selection and refinement of screening strategies, thereby facilitating the discovery and development of lead compounds for anti-SARS-CoV-2 pharmaceuticals.
Insights
This review highlights fluorescence-based assays for screening SARS-CoV-2 viral proteins like Spike, 3CLpro, and RdRp. These methods are crucial for discovering new COVID-19 antiviral drugs.
Area of Science:
- Virology
- Drug Discovery
- Biochemistry
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, presents a global health and economic challenge.
- Five key viral proteins—Spike, 3CLpro, PLpro, RdRp, and Helicase—are critical for SARS-CoV-2 invasion and replication.
- Targeting these proteins offers a promising strategy for developing novel antiviral therapeutics.
Purpose of the Study:
- To review and elucidate the principles of fluorescence-based screening assays for five pivotal SARS-CoV-2 viral proteins.
- To guide researchers in selecting and refining screening strategies for anti-SARS-CoV-2 drug discovery.
- To facilitate the identification and development of lead compounds against SARS-CoV-2.
Main Methods:
- Focuses on fluorescence-based assay methodologies.
- Discusses screening approaches tailored for viral Spike, 3CLpro, PLpro, RdRp, and Helicase.
- Emphasizes high-throughput screening techniques for efficiency.
Main Results:
- Identifies fluorescence-based assays as predominant screening techniques.
- Provides foundational principles and methodologies for these assays.
- Highlights the importance of efficient screening for drug development.
Conclusions:
- Fluorescence-based assays are vital for high-throughput screening of SARS-CoV-2 targets.
- Effective screening methodologies accelerate the discovery of potential anti-COVID-19 drugs.
- This review serves as a guide for optimizing antiviral drug development strategies.
More Related Videos
Related Concept Videos
Viral Mutations
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Single Nucleotide Polymorphisms-SNPs
Coronavirus

